Proliferative activity of micrometastases in the lymph nodes of patients with gastric cancer

British Journal of Surgery

Volumn 94, Issue 6, 2007, Pages 731-736

  Yonemura, Y ^a   Endo, Y ^b   Hayashi, I ^a   Kawamura, T ^a   Yun, H Y ^c   Bandou, E ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN ANTIBODY; KI 67 ANTIGEN;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 34250369523     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5604     Document Type: Article

References (23)

1. Kubota K, Nakanishi H, Hiki N, Shimizu N, Tsuji E, Yamaguchi H et al. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Int J Cancer 2003; 105: 136-143.
2. Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 2001; 8: 158-162.
3. Macadam R, Sarela A, Wilson J, MacLennan K, Guillou P. Bone marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma. Eur J Surg Oncol 2003; 29: 450-454.
4. Calaluce R, Miedema BW, Yesus YW. Micrometastasis in colorectal carcinoma: a review. J Surg Oncol 1998; 67: 194-202.
5. Hermanek P, Hutter RVP, Sobin LH, Witterkind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-2673.
6. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma (2nd English edn). Gastric Cancer 1998; 1: 10-24.
7. Cserni G, Bianchi S, Boecker W, Decker T, Lacerda T, Rank F et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2004; 103: 358-367.
8. Cai J, Ikeguchi M, Maeta M, Kaibara N, Sakatani T. Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer. Gastric Cancer 1999; 2: 95-100.
9. Funk I, Schrout W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998; 16: 557-566.
10. Bando E, Kawamura T, Kinoshita K, Takahashi S, Maeda A, Osada S et al. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer. J Am Coll Surg 2003; 197: 212-222.
11. Sobin LH, Wittekind C (eds). International Union Against Cancer. TNM Classification of Malignant Tumours (6th edn). Wiley-Liss: New York, 2002.
12. Siewert JR, Kestlmeier R, Busch R, Bottcher K, Roder JD, Muller J et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996; 83: 1144-1147.
13. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997; 79: 1069-1076.
14. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in 'node-negative' colorectal cancer. J Gastroenterol 1997; 32: 758-764.
15. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G et al. Differential expression of proliferating-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993; 85: 1419-1424.
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
17. Yonemura Y, Ooyama S, Sugiyama K, Ninomiya I, Kamata T, Yamaguchi A et al. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer 1990; 65: 1130-1134.
18. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartsz WH et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14: 831-838.
19. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P et al. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol 2001; 21: 3436-3444.
20. Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM. Suppressor of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 2000; 6: 1335-1340.
21. Urano N, Fujiwara Y, Doki Y, Tsujie M, Yamamoto H, Miyata H et al. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 2006; 9: 44-49.
22. Fukagawa T, Sasako M, Mann GB, Sano T, Katai H, Maruyama K et al. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 2001; 92: 753-760.
23. Natsugoe S, Nakashima S, Matsumoto M, Nakajo A, Miyazono F, Kijima F et al. Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma. Gastric Cancer 1999; 2: 179-185.